Chen Lee Won
Partner
Lee Won’s areas of practice include foreign investment into Malaysia, public and private M&As, corporate restructuring, joint ventures, securities laws and general commercial contracts.
She has represented clients from a broad spectrum of industries, including financial institutions, manufacturers, healthcare providers, oil and gas entities, private equity firms and sovereign funds on domestic and cross-border transactions.
Lee Won has written articles on securities offering, takeovers and business acquisitions, and banking regulation in Malaysia for various publications.
Lee Won is recognised as Highly Regarded in M&A by IFLR1000 and is endorsed by peers and clients as being “diligent with prompt and detailed responses”. She is consistently recognised as a Leading Individual in Corporate and M&A by The Legal 500 Asia Pacific and also in Corporate/M&A by Chambers Global/Asia-Pacific. In Chambers Asia-Pacific, sources say that “she knows her stuff”. She was described as “really sharp and commercially savvy”, and was noted for her “proactivity in coming up with solutions”.
Lee Won joined the Firm in 2011 and Rahmat Lim & Partners, Kuala Lumpur in 2013. Prior to joining the Firm, she was a Partner of a law firm in Malaysia.
Lee Won is concurrently a Partner in Rahmat Lim & Partners, the Firm's associate Firm in Malaysia. To read more about her practice in Malaysia, please click here.
Work Highlights
- Advised GuocoLand in its strategic partnership with Eco World Development Group in relation to Eco World International.
- Advised Dialog Group on the development cum joint venture agreement with the State Government of Johor to build and operate a deepwater terminal in Pengerang, Johor, and on various transactions involving, inter alia, the development, construction and operation of facilities at Pengerang for an independent tank terminal, a dedicated tank terminal, and LNG regasification facilities and storage tanks.
- Advising Adventa Capital on its proposed disposal of the entire equity interest in Aspion, a company with subsidiaries principally involved in, amongst other things, the manufacturing and distribution of disposable sterile surgical gloves and medical examination and protection gloves, to Top Care, a wholly-owned subsidiary of Top Glove Corporation, for a consideration of RM1.37 billion.